Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential vs Triple Therapy for H. pylori Infection
NCT01607918Phase 4
Key facts
- Status
- Unknown
- Start
- Feb 2012
- Primary completion
- Dec 2013
- Countries
- 1
- Sponsor
- National Taiwan University Hospital
- Modality
- Small Molecules
- Conditions
- Helicobacter pylori infection
01
Overview
Phase 4, randomised, open-label trial of lansoprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection, sponsored by National Taiwan University Hospital. Status: unknown.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Adults (>20 years) with H. pylori infection who have not received prior eradication therapy.
04
Registry description
The investigators aimed to compare the eradication rates of sequential therapy for 10 days versus triple therapy for 14 days
Beyond the preview
Go deeper on NCT01607918.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01607918.